Can hyperthermic intraperitoneal chemotherapy effectively control gastric cancer-associated peritoneal carcinomatosis?

• 作者: Chao-Jung Tsao Chong-Chi Chiu Jhi-Joung Wang Yutaka Yonemura
• 来源期刊: 世界外科手术杂志
• 学科: 医学
• 关键词: Hyperthermic INTRAPERITONEAL CHEMOTHERAPY GASTRIC cancer PERITONEAL CARCINOMATOSIS
• 年，卷（期）: 2019,（1）
• 页码范围: 7-11
• 页数: 5页
• 分类号: R

摘要

Gastric cancer-associated peritoneal carcinomatosis leads to a poor prognosis and low quality of life. The current systemic chemotherapy processes cannot effectively improve survival. Hyperthermic intraperitoneal chemotherapy (HIPEC) has been used as an alternative treatment to control this disease through recurrence prevention, definitive therapeutic modality, and symptom palliation. Although HIPEC has been demonstrated to yield favorable results mainly in some Asian studies, widespread adoption of this treatment is still debatable before larger prospective randomized controlled clinical trials confirm its effectiveness.